Concourse Financial Group Securities, Inc. Cognition Therapeutics Inc Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
16 transactions
Others Institutions Holding CGTX
# of Institutions
62Shares Held
18MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$9.96 Million2.56% of portfolio
-
Davenport & CO LLC2.69MShares$4.46 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.68MShares$4.45 Million0.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$3.66 Million0.02% of portfolio
-
Acadian Asset Management LLC Boston, MA702KShares$1.17 Million0.0% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $37.7M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...